MU42 SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
UL. REFORMACKA 6, 35-026 RZESZÓW
TAX ID8133849945
Rate company:
MU42 SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
TAX ID8133849945
KRS0000876279
Share capital7,500.00 zł
address
UL. REFORMACKA 6, 35-026 RZESZÓW
Categories
Main category
Is this your company?Update company information to get new customers, get notified of new reviews, and more!
Register Data
NIP
8133849945 
REGON
387795726
KRS
0000876279
Legal form
limited liability company
Register Address
UL. REFORMACKA 6, 35-026 RZESZÓW
Date of registration in KRS
2020-12-29
Date of commencement of economic activity
2020-12-29
Act signature
RDF/671413/24/64
Pkd codes
72.11.Z - Research and experimental development on biotechnology
21.20.Z - Manufacture of medicines and other pharmaceutical products
62.01.Z - Computer programming activities
62.09.Z - Other information technology and computer service activities
63.11.Z - Data processing, hosting and related activities
63.12.Z - Web portals
63.99.Z - Other information service activities not elsewhere classified
72.19.Z - Other research and experimental development on natural sciences and engineering
72.20.Z - Research and experimental development on social sciences and humanities
74.90.Z - Other professional, scientific and technical activities not elsewhere classified
Payer VAT status
Active
Vat list bank account(s)
PL50 1140 2004 0000 3302 8098 1350 
Financial data
Net sales [PLN]
Gross profit / loss [PLN]
Automatically generated based on financial statements from KRS Registry
| 2021 | 2022 | 2023 | ||
|---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss)  | 0 | -0 | -0 | 71,7 |
EBITDA | 0 | -0 | 0 | 101,2 |
Short time liabilities | 0 | 0,1 | 0,1 | 10,4 |
Equity capital | 0 | 0,2 | 0,2 | 16,7 |
Operating profit (EBIT) | 0 | -0 | 0 | 101,2 |
Assets | 0 | 0,3 | 1,2 | 384,7 |
Net profit (loss) | 0 | -0 | -0 | 71,7 |
Cash | 0 | 0,2 | 0 | -99 |
Net income from sale | 0 | 0,1 | 0 | -99,4 |
Liabilities and provisions for liabilities | 0 | 0,1 | 1 | 1757,8 |
Working assets | 0 | 0,3 | 0,1 | -71,5 |
Depreciation | 0 | 0 | 0 | 0 |
% | % | % | p.p. | |
Profitability of capital | 0 | -20,3 | -4,9 | 15,4 |
Equity capital to total assets | 100 | 78,9 | 19 | -59,9 |
Gross profit margin | -55 | -2561,6 | -2506,6 | |
EBITDA Margin | -54,8 | 112,2 | 167 | |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 0 | 265 | 48 169 | 47 904 |
Current financial liquidity indicator | 4.73192834854126 | 0.07247336953878403 | -4,6 | |
Net dept to EBITDA | 6.0403594970703125 | 109.00279235839844 | 103 |
Financial statements
01-01-2023 - 31-12-2023
Annual financial report
Download xml01-01-2023 - 31-12-2023
Annual financial report
Download pdf01-01-2023 - 31-12-2023
Resolution or decision approving the annual financial statements
Download pdf01-01-2023 - 31-12-2023
Resolution on profit distribution or loss coverage
Download pdf01-01-2023 - 31-12-2023
Activity report
Download pdfShow more (2)
uses security reCAPTCHA
Opinions
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane
0/ 5.0
How do you rate this company?
Your opinion matters to us.
Companies registered in the same sector
KAROLINA BADORA
Romanówka
Molecular Biotech Mateusz Gielata
Warszawa
INVIGEN SPÓŁKA AKCYJNA
WARSZAWA